Application | Comment | Organism |
---|---|---|
medicine | activation of antitumor prodrugs | Mus musculus |
Cloned (Comment) | Organism |
---|---|
- |
Mus musculus |
- |
Homo sapiens |
- |
Rattus norvegicus |
Inhibitors | Comment | Organism | Structure |
---|---|---|---|
3,3'-methylene-bis(4-hydroxycoumarin) | - |
Homo sapiens | |
3,3'-methylene-bis(4-hydroxycoumarin) | - |
Mus musculus | |
3,3'-methylene-bis(4-hydroxycoumarin) | - |
Rattus norvegicus | |
5,7-dihydroxyflavone | - |
Homo sapiens | |
5,7-dihydroxyflavone | - |
Mus musculus | |
5,7-dihydroxyflavone | - |
Rattus norvegicus |
KM Value [mM] | KM Value Maximum [mM] | Substrate | Comment | Organism | Structure |
---|---|---|---|---|---|
0.025 | - |
5-(1-aziridinyl)-3-(hydroxymethyl)-2-(3-hydroxy-1-propenyl)-1-methyl-1H-indole-4,7-dione | - |
Homo sapiens | |
0.027 | - |
5-(1-aziridinyl)-3-(hydroxymethyl)-2-(3-hydroxy-1-propenyl)-1-methyl-1H-indole-4,7-dione | - |
Rattus norvegicus | |
0.04 | - |
5-(1-aziridinyl)-3-(hydroxymethyl)-2-(3-hydroxy-1-propenyl)-1-methyl-1H-indole-4,7-dione | - |
Mus musculus | |
0.1 | - |
NADH | - |
Homo sapiens | |
0.11 | - |
NADH | - |
Rattus norvegicus | |
0.12 | - |
NADH | - |
Mus musculus | |
0.84 | - |
5-(aziridin-1-yl)-4-hydroxylamino-2-benzamide | - |
Rattus norvegicus | |
1.28 | - |
5-(aziridin-1-yl)-4-hydroxylamino-2-benzamide | - |
Mus musculus | |
1.37 | - |
5-(aziridin-1-yl)-4-hydroxylamino-2-benzamide | - |
Homo sapiens |
Organism | UniProt | Comment | Textmining |
---|---|---|---|
Homo sapiens | - |
- |
- |
Mus musculus | - |
- |
- |
Rattus norvegicus | - |
- |
- |
Purification (Comment) | Organism |
---|---|
recombinant enzyme | Mus musculus |
recombinant enzyme | Homo sapiens |
recombinant enzyme | Rattus norvegicus |
Substrates | Comment Substrates | Organism | Products | Comment (Products) | Rev. | Reac. |
---|---|---|---|---|---|---|
2-methyl-1,4-naphthoquinone + NAD(P)H | - |
Mus musculus | 2-methyl-1,4-naphthoquinol + NAD(P)+ | - |
? | |
2-methyl-1,4-naphthoquinone + NAD(P)H | - |
Rattus norvegicus | 2-methyl-1,4-naphthoquinol + NAD(P)+ | - |
? | |
2-methyl-1,4-naphthoquinone + NAD(P)H | involved in the process of reductive activation of several cytotoxic antitumor quinones, such as mitomycins, anthracyclines and azaridinylbenzoquinones | Homo sapiens | 2-methyl-1,4-naphthoquinol + NAD(P)+ | - |
? | |
5-(1-aziridinyl)-3-(hydroxymethyl)-2-(3-hydroxy-1-propenyl)-1-methyl-1H-indole-4,7-dione + NAD(P)H | - |
Mus musculus | 5-(1-aziridinyl)-3-(hydroxymethyl)-2-(3-hydroxy-1-propenyl)-1-methyl-1H-indole-4,7-diol + NAD(P)+ | - |
? | |
5-(1-aziridinyl)-3-(hydroxymethyl)-2-(3-hydroxy-1-propenyl)-1-methyl-1H-indole-4,7-dione + NAD(P)H | - |
Homo sapiens | 5-(1-aziridinyl)-3-(hydroxymethyl)-2-(3-hydroxy-1-propenyl)-1-methyl-1H-indole-4,7-diol + NAD(P)+ | - |
? | |
5-(1-aziridinyl)-3-(hydroxymethyl)-2-(3-hydroxy-1-propenyl)-1-methyl-1H-indole-4,7-dione + NAD(P)H | - |
Rattus norvegicus | 5-(1-aziridinyl)-3-(hydroxymethyl)-2-(3-hydroxy-1-propenyl)-1-methyl-1H-indole-4,7-diol + NAD(P)+ | - |
? | |
5-(aziridin-1-yl)-2,4-dinitrobenzamide + NAD(P)H | - |
Mus musculus | 5-(aziridin-1-yl)-4-hydroxylamino-2-nitrobenzamide + NAD(P)+ | - |
? | |
5-(aziridin-1-yl)-2,4-dinitrobenzamide + NAD(P)H | - |
Homo sapiens | 5-(aziridin-1-yl)-4-hydroxylamino-2-nitrobenzamide + NAD(P)+ | - |
? | |
5-(aziridin-1-yl)-2,4-dinitrobenzamide + NAD(P)H | - |
Rattus norvegicus | 5-(aziridin-1-yl)-4-hydroxylamino-2-nitrobenzamide + NAD(P)+ | - |
? | |
5-(aziridin-1-yl)-2,4-dinitrobenzamide + reduced dihydronicotineamide riboside | - |
Mus musculus | 5-(aziridin-1-yl)-4-hydroxylamino-2-nitrobenzamide + oxidized dihydronicotineamide riboside | - |
? | |
5-(aziridin-1-yl)-2,4-dinitrobenzamide + reduced dihydronicotineamide riboside | - |
Homo sapiens | 5-(aziridin-1-yl)-4-hydroxylamino-2-nitrobenzamide + oxidized dihydronicotineamide riboside | - |
? | |
5-(aziridin-1-yl)-2,4-dinitrobenzamide + reduced dihydronicotineamide riboside | - |
Rattus norvegicus | 5-(aziridin-1-yl)-4-hydroxylamino-2-nitrobenzamide + oxidized dihydronicotineamide riboside | - |
? | |
menadione + NADH + H+ | - |
Mus musculus | menadiol + NAD+ | - |
r |
Ki Value [mM] | Ki Value maximum [mM] | Inhibitor | Comment | Organism | Structure |
---|---|---|---|---|---|
0.07 | - |
5,7-dihydroxyflavone | - |
Homo sapiens | |
0.08 | - |
5,7-dihydroxyflavone | - |
Rattus norvegicus | |
0.68 | - |
5,7-dihydroxyflavone | - |
Mus musculus |